Suppr超能文献

新型冠状病毒肺炎疫情期间临床药师在方舱医院的作用及价值评估

Evaluation of the role and usefulness of clinical pharmacists at the Fangcang Hospital during COVID-19 outbreak.

作者信息

Wang Dongyuan, Liu Yihui, Zeng Fang, Shi Chen, Cheng Fang, Han Yong, Zhang Yu

机构信息

Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, China.

出版信息

Int J Clin Pract. 2021 Aug;75(8):e14271. doi: 10.1111/ijcp.14271. Epub 2021 May 13.

Abstract

BACKGROUND

Fangcang Hospitals (cabin hospitals) played a key role in isolation and control of the infection sources during COVID-19 epidemic. Many patients at Fangcang Hospitals had complications or mental stress. As the doctors, nurses and paramedics presented in the emergency, there was a growing demand for clinical pharmacists to provide pharmaceutical care for the affected patients with chronic diseases via telemedicine.

OBJECTIVE

This study was a retrospective study to evaluate the usefulness of clinical prevention and control measures of clinical pharmacists at Jianghan Fangcang Hospital. Besides, this study proposed innovative strategies for developing pharmacy services to ensure the medication compliance, accuracy and cure rates under the epidemic.

METHODS

A total of 374 patients filled in the questionnaires and 349 patients were enrolled in this study. Patients who refused to receive pharmaceutical care were not included in this study. The pharmaceutical care included medication education via broadcast station, medication reconciliation, optimisation of drug use, monitor of adverse drug events and psychological comfort via WeChat one-to-one service. The data were collected from patients' interviews and the questionnaires of inpatients and discharged patients.

RESULTS

In Jianghan Fangcang Hospital, many patients had complications with hypertension (12.9%), hyperlipidaemia (9.2%), thyroid disease (8.9%), diabetes (7.2%), heart disease (3.4%), nephropathy (1.7%), cancer (1.1%) and other diseases (12.6%). After 35 days' pharmacy service, about 200 different questions had been solved by our clinical pharmacists, including drug usage (65.38%), medication reconciliation (55.13%), drug precautions (23.1%), adverse drug reactions (35.9%) and psychological counselling (32.05%). Most patients were satisfied with clinical pharmacist service (66.7% great, 18.0% good).

CONCLUSION

The results of the retrospective study indicated that clinical pharmacist can effectively reduce and prevent drug-related, life-related and COVID-19-related problems for COVID-19 patients, which is important for the disease recovery. This study also demonstrated that clinical pharmacist played a key role for patients' healthcare during the pandemic.

摘要

背景

方舱医院在新型冠状病毒肺炎疫情期间的传染源隔离与控制中发挥了关键作用。许多方舱医院的患者出现了并发症或精神压力。随着医生、护士和医护人员奔赴紧急情况现场,临床药师通过远程医疗为受影响的慢性病患者提供药学服务的需求日益增长。

目的

本研究是一项回顾性研究,旨在评估江汉方舱医院临床药师的临床防控措施的有效性。此外,本研究提出了在疫情期间发展药学服务的创新策略,以确保用药依从性、准确性和治愈率。

方法

共有374名患者填写了问卷,349名患者纳入本研究。拒绝接受药学服务的患者未纳入本研究。药学服务包括通过广播电台进行用药教育、用药核对、优化药物使用、监测药物不良事件以及通过微信一对一服务提供心理安慰。数据收集自患者访谈以及住院患者和出院患者的问卷。

结果

在江汉方舱医院,许多患者患有并发症,包括高血压(12.9%)、高脂血症(9.2%)、甲状腺疾病(8.9%)、糖尿病(7.2%)、心脏病(3.4%)、肾病(1.7%)、癌症(1.1%)和其他疾病(12.6%)。经过35天的药学服务,我们的临床药师解决了约200个不同的问题,包括药物使用(65.38%)、用药核对(55.13%)、药物注意事项(23.1%)、药物不良反应(35.9%)和心理咨询(32.05%)。大多数患者对临床药师服务满意(66.7%非常满意,18.0%满意)。

结论

回顾性研究结果表明,临床药师可以有效减少和预防新型冠状病毒肺炎患者的药物相关、生活相关和新型冠状病毒肺炎相关问题,这对疾病康复很重要。本研究还表明,临床药师在疫情期间对患者的医疗保健发挥了关键作用。

相似文献

1
Evaluation of the role and usefulness of clinical pharmacists at the Fangcang Hospital during COVID-19 outbreak.
Int J Clin Pract. 2021 Aug;75(8):e14271. doi: 10.1111/ijcp.14271. Epub 2021 May 13.
2
Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic.
J Am Pharm Assoc (2003). 2020 May-Jun;60(3):431-438.e1. doi: 10.1016/j.japh.2020.04.006. Epub 2020 Apr 10.
3
[Medication reconciliation on admission: One year of practice in health care institutions during the COVID-19 pandemic].
Ann Pharm Fr. 2023 Sep;81(5):863-874. doi: 10.1016/j.pharma.2023.01.004. Epub 2023 Jan 31.
5
The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge.
Int J Clin Pharm. 2023 Feb;45(1):117-125. doi: 10.1007/s11096-022-01496-3. Epub 2022 Nov 3.
6
Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
Res Social Adm Pharm. 2021 Aug;17(8):1507-1517. doi: 10.1016/j.sapharm.2020.11.017. Epub 2020 Nov 30.
7
Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use.
Int J Clin Pharm. 2018 Oct;40(5):1154-1164. doi: 10.1007/s11096-018-0650-8. Epub 2018 May 12.
9
Management of COVID-19 patients in Fangcang shelter hospital: clinical practice and effectiveness analysis.
Clin Respir J. 2021 Mar;15(3):280-286. doi: 10.1111/crj.13293. Epub 2020 Oct 28.

引用本文的文献

1
Bibliometric and visual analysis of medication therapy management from 2003 to 2023.
Medicine (Baltimore). 2024 Dec 20;103(51):e40953. doi: 10.1097/MD.0000000000040953.
2
Telepharmacy Implementation to Support Pharmaceutical Care Services during the COVID-19 Pandemic: A Scoping Review.
Can J Hosp Pharm. 2024 Jan 10;77(1):e3430. doi: 10.4212/cjhp.3430. eCollection 2024.
8
Hyperlipidemia, COVID-19 and acute pancreatitis: A tale of three entities.
Am J Med Sci. 2022 Sep;364(3):257-263. doi: 10.1016/j.amjms.2022.03.007. Epub 2022 Apr 4.
9
Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments.
Int J Environ Res Public Health. 2021 Nov 8;18(21):11711. doi: 10.3390/ijerph182111711.

本文引用的文献

1
COVID-19, a worldwide public health emergency.
Rev Clin Esp (Barc). 2021 Jan;221(1):55-61. doi: 10.1016/j.rceng.2020.03.001. Epub 2020 Apr 21.
2
Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19.
Gastroenterology. 2021 Apr;160(5):1880. doi: 10.1053/j.gastro.2020.05.044. Epub 2020 May 18.
3
Fangcang shelter hospitals: a novel concept for responding to public health emergencies.
Lancet. 2020 Apr 18;395(10232):1305-1314. doi: 10.1016/S0140-6736(20)30744-3. Epub 2020 Apr 2.
4
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
5
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.
6
Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics.
Lancet Respir Med. 2020 Mar;8(3):e11-e12. doi: 10.1016/S2213-2600(20)30071-0. Epub 2020 Feb 13.
7
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.
Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.
9
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验